C07D 279/02
1,2-thiazines
Official title: 1,2-Thiazines; Hydrogenated 1,2-thiazines
C07D279/02 (1,2-thiazines) appears on 150 US grants and 120 published applications in this corpus.
Search patents in C07D- Granted patents
- 150
- Published applications
- 120
- Assignees
- 103
- Inventors
- 546
- Latest grant
- 25 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 1 | 0 |
| 1978 | 4 | 0 |
| 1979 | 0 | 0 |
| 1980 | 2 | 0 |
| 1981 | 3 | 0 |
| 1982 | 2 | 0 |
| 1983 | 3 | 0 |
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 3 | 0 |
| 1987 | 2 | 0 |
| 1988 | 2 | 0 |
| 1989 | 8 | 0 |
| 1990 | 2 | 0 |
| 1991 | 4 | 0 |
| 1992 | 4 | 0 |
| 1993 | 3 | 0 |
| 1994 | 3 | 0 |
| 1995 | 2 | 0 |
| 1996 | 4 | 0 |
| 1997 | 2 | 0 |
| 1998 | 3 | 0 |
| 1999 | 5 | 0 |
| 2000 | 0 | 0 |
| 2001 | 6 | 1 |
| 2002 | 4 | 6 |
| 2003 | 7 | 5 |
| 2004 | 2 | 12 |
| 2005 | 3 | 6 |
| 2006 | 3 | 7 |
| 2007 | 5 | 2 |
| 2008 | 5 | 6 |
| 2009 | 5 | 5 |
| 2010 | 2 | 4 |
| 2011 | 3 | 2 |
| 2012 | 2 | 1 |
| 2013 | 1 | 2 |
| 2014 | 1 | 6 |
| 2015 | 7 | 7 |
| 2016 | 4 | 7 |
| 2017 | 2 | 5 |
| 2018 | 1 | 7 |
| 2019 | 3 | 1 |
| 2020 | 1 | 4 |
| 2021 | 2 | 3 |
| 2022 | 3 | 7 |
| 2023 | 1 | 2 |
| 2024 | 1 | 6 |
| 2025 | 7 | 1 |
| 2026 | 0 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Herbicidal compounds25 Nov 2025US 12,479,804 B2Syngenta Crop Protection AG
- Urolithin derivatives and methods of use thereof18 Nov 2025US 12,473,269 B2Vandria SA
- Telomerase reverse transcriptase (TERT) expression enhancing compounds and methods for using the same2 Sep 2025US 12,404,304 B1Sierra Sciences, Inc.
- Urolithin derivatives and methods of use thereof15 Jul 2025US 12,358,884 B2Vandria SA
- Urolithin derivatives and methods of use thereof8 Jul 2025US 12,351,567 B2Vandria SA
- Electrophilic reactive linkers for labeling of polypeptides and methods of use thereof25 Jun 2026US 2026/0174880 A1President and Fellows of Harvard College
- Urolithin derivatives and methods of use thereof14 May 2026US 2026/0132117 A1Vandria SA
- Process for the fluorination and/or cyclization of an amino alkene or alkyne in a continuous stream and facility for performing the process7 May 2026US 2026/0125349 A1Centre National De La Recherche Scientifique
- Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer19 Mar 2026US 2026/0078091 A1Amgen Inc.
- Compositions and methods for inducing ferroptosis5 Feb 2026US 2026/0034094 A1Kojin Therapeutics, Inc.
Most cited
By later US patents
- 4-Hydroxy-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxides and salts thereof142US 4,233,299 ABoehringer Ingelheim GmbH · 1980
- Medicaments for the treatment of disorders of lipometabolism and their use138US 4,405,644 ABayer Aktiengesellschaft · 1983
- Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors60US 5,811,422 AThe DuPont Merck Pharmaceutical Company · 1998
- Hydroxyethylamine derivatives for the treatment of Alzheimer's disease52US 7,253,198 B2Glaxo Group Limited · 2007
- Substituted phenanthridinones and methods of use thereof49US 6,476,048 B1Inotek Pharamaceuticals Corporation · 2002